Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Identify key moments to de-risk in retirement, using timing signals to reduce exposure while preserving income.
27,016 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
What the arcturus (arct) 2025 earnings report may reveal isn’t just about a single quarter. This guide breaks down th...
A sudden explosion at Valero’s Port Arthur refinery prompted a temporary shutdown, sending ripples through energy mar...
As clean energy goals rise, two small modular reactor players, Oklo and NuScale Power, stand out. This guide breaks d...
Sellers often chase the highest bid, but the strongest offers hinge on terms that reduce risk. This report explains h...
As Daré gears up to discuss Q1 2026 results, investors will scrutinize cash runway, pipeline milestones, and strategi...
Two very different paths define the nuclear renaissance: NuScale's small modular reactors and BWX Technologies' broad...
Eli Lilly is shaking up its growth plan by expanding beyond obesity with new infectious disease initiatives. This art...
Lawmakers and insurers are weighing a faster disaster payout model that would centralize leadership and pool risk to ...
Investors are eyeing the microreactor trend and Nano Nuclear Energy. This guide breaks down the potential, risks, and...
AST SpaceMobile just completed a trio of successful BlueBird launches, yet spacemobile's stock down after the event. ...
Rocket Lab is pursuing a bold $8 billion strategy to merge rocket launches, satellites, and data services. Learn what...